Microbial cell membrane (targeted for disruption)

Microbial cell membrane disruption refers to the pharmacological strategy of attacking or destabilizing the lipid bilayer constituting the bacterial cell envelope. While not itself a molecular target (e.g., a receptor or enzyme), the cell membrane is essential for bacterial viability, mediating functions such as transport, energy generation, and maintenance of homeostasis. Some antibiotics and antimicrobial peptides act by integrating into or binding to specific lipids (such as phosphatidylglycerol and cardiolipin), leading to loss of membrane integrity, pore formation, leakage of cell contents, depolarization, and ultimately cell death. Agents like daptomycin, polymyxins, and certain lantibiotics (e.g., nisin, mutacin 1140) exemplify this mechanism. Such drugs typically show higher affinity for microbial than mammalian membranes due to lipid composition differences, but off-target effects remain a potential safety concern. Cell membrane disruption is associated with broad-spectrum bactericidal activity and a lower propensity to resistance, though it is not a classical molecular target in the drug discovery sense[1][2][3][4][5]. Caveat: "Microbial cell membrane disruption" describes a *mechanism of action* rather than a discrete molecule or receptor. The microbial cell membrane is a structure composed of diverse molecules and is not uniquely defined at the protein or gene level, making this "target" inherently non-canonical for structured databases.

Other names

Bacterial membraneBacterial cell membraneProkaryotic cell membrane

Direct disruption of membrane integrity (lysis, leakage of cell contents) Pore formation Binding to lipid II (inhibition of bacterial cell wall synthesis) Dissipation of membrane potential/proton motive force